MYC and cancer: The above results indicated that DVL3 promoted cancer cell metastasis and multidrug resistance, and maintained EMT and cancer-stem-like cells (CSLCs) phenotypes through the Wnt/β-catenin/c-Myc/SOX2 axis (Li et al., 2023).